Merit Medical Systems Inc- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 Merit Medical Systems Inc 公司

Merit Medical Systems, Inc. 从事专有医疗设备的开发、制造和分销，这些设备用于介入、诊断和治疗程序，特别是心脏病学、放射学、肿瘤学、重症监护和内窥镜检查。其部门包括心血管和内窥镜检查。其心血管部门包括四个产品类别：外周介入、心脏介入、定制程序解决方案和原始设备制造商 (OEM)。其内窥镜部门包括胃肠病学和肺病学设备，这些设备可帮助姑息治疗扩张的食管、气管支气管和胆道狭窄。其医疗设备和配件产品组合用于导线管理程序，适用于需要移除或更换起搏器或植入式心律转复除颤器导线的患者。其电生理学和心律管理产品组合包括可操纵技术和其他专业技术。

Merit Medical Systems Inc简介



公司代码MMSI

公司名称Merit Medical Systems Inc

上市日期Sep 16, 1954

CEO- -

员工数量7400

证券类型Ordinary Share

年结日Sep 16

公司地址1600 West Merit Park Way

城市SOUTH JORDAN

上市交易所NASDAQ Global Select Consolidated

国家United States of America

邮编84095

电话18012531600

网址https://www.merit.com/

公司代码MMSI

上市日期Sep 16, 1954

CEO- -

Merit Medical Systems Inc公司高管



名称

名称/职务

职务

持股

持股变动

Mr. Fred P. Lampropoulos

Chairman of the Board

1.15M

+3.09%

Mr. Thomas James Gunderson

Independent Director

36.03K

+6.35%

Mr. Brian G. Lloyd

Chief Legal Officer, Corporate Secretary

21.70K

-44.35%

Ms. Martha Goldberg Aronson, Jr.

President, Chief Executive Officer, Director

19.59K

--

Mr. David K. Floyd

Independent Director

18.58K

+13.10%

Mr. Lonny J. Carpenter

Independent Director

17.37K

+14.14%

Mr. Neil W. Peterson

Chief Operating Officer

16.61K

--

Rear Adm. (Retd.) Stephen C. Evans

Independent Director

6.81K

+46.21%

Mr. Michael R. (Mike) McDonnell, CPA

Independent Director

3.96K

-30.63%

Dr. F. Ann Millner, Ed.D.

Lead Independent Director

--

名称

名称/职务

职务

持股

持股变动

Mr. Fred P. Lampropoulos

Chairman of the Board

1.15M

+3.09%

Mr. Thomas James Gunderson

Independent Director

36.03K

+6.35%

Mr. Brian G. Lloyd

Chief Legal Officer, Corporate Secretary

21.70K

-44.35%

Ms. Martha Goldberg Aronson, Jr.

President, Chief Executive Officer, Director

19.59K

--

Mr. David K. Floyd

Independent Director

18.58K

+13.10%

Mr. Lonny J. Carpenter

Independent Director

17.37K

+14.14%

收入明细

单位: USD更新时间: 10月6日周一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

Peripheral Intervention

142.85M

37.35%

Cardiac Intervention

115.25M

30.13%

Custom Procedural Solutions

53.63M

14.02%

OEM

52.29M

13.67%

Endoscopy devices

18.44M

4.82%

地区USD

名称

营收

占比

United States

227.08M

59.37%

International

155.38M

40.63%

业务

地区

业务USD

名称

营收

占比

Peripheral Intervention

142.85M

37.35%

Cardiac Intervention

115.25M

30.13%

Custom Procedural Solutions

53.63M

14.02%

OEM

52.29M

13.67%

Endoscopy devices

18.44M

4.82%

股东统计

更新时间: 11月5日周三

持股股东

股东类型

持股股东

占比

BlackRock Institutional Trust Company, N.A.

13.45%

The Vanguard Group, Inc.

11.18%

State Street Investment Management (US)

3.74%

Conestoga Capital Advisors, LLC

3.69%

Fuller & Thaler Asset Management Inc.

3.07%

其他

64.87%

持股股东

占比

BlackRock Institutional Trust Company, N.A.

13.45%

The Vanguard Group, Inc.

11.18%

State Street Investment Management (US)

3.74%

Conestoga Capital Advisors, LLC

3.69%

Fuller & Thaler Asset Management Inc.

3.07%

其他

64.87%

股东类型

持股股东

占比

Investment Advisor

56.82%

Investment Advisor/Hedge Fund

33.45%

Hedge Fund

11.03%

Research Firm

2.43%

Individual Investor

2.37%

Bank and Trust

2.04%

Pension Fund

1.65%

Sovereign Wealth Fund

1.02%

Family Office

0.41%

机构持股



更新时间: 10月1日周三

报告期

机构数

持股数

持股占比

持股变动

2025Q3

736

64.29M

108.43%

-3.60M

2025Q2

756

65.62M

110.80%

-760.05K

2025Q1

779

66.66M

112.79%

+221.37K

2024Q4

755

63.98M

108.78%

+576.77K

2024Q3

725

62.16M

106.75%

-1.49M

2024Q2

695

63.02M

108.42%

-345.52K

2024Q1

677

61.08M

105.16%

-692.46K

2023Q4

651

59.77M

103.51%

-88.47K

2023Q3

637

57.87M

100.40%

-723.38K

2023Q2

625

56.54M

98.35%

-2.22M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

BlackRock Institutional Trust Company, N.A.

7.97M

13.46%

-206.62K

-2.53%

Jun 30, 2025

The Vanguard Group, Inc.

6.82M

11.51%

+257.10K

+3.92%

Jun 30, 2025

State Street Investment Management (US)

2.22M

3.75%

+24.57K

+1.12%

Jun 30, 2025

Conestoga Capital Advisors, LLC

2.21M

3.73%

-53.58K

-2.37%

Jun 30, 2025

Fuller & Thaler Asset Management Inc.

1.82M

3.07%

+52.67K

+2.98%

Jun 30, 2025

Macquarie Investment Management

1.46M

2.46%

+4.15K

+0.29%

Jun 30, 2025

Fidelity Management & Research Company LLC

1.45M

2.44%

-24.93K

-1.69%

Jun 30, 2025

Geode Capital Management, L.L.C.

1.44M

2.43%

+39.62K

+2.83%

Jun 30, 2025

Two Sigma Investments, LP

1.40M

2.37%

+364.22K

+35.02%

Jun 30, 2025

Maverick Capital, Ltd.

1.38M

2.33%

+106.90K

+8.40%

Jun 30, 2025

持股ETF



更新时间: 11月6日周四

机构名称

占比

Invesco S&P SmallCap Health Care ETF

3.13%

First Trust Indxx Medical Devices ETF

1.7%

SPDR S&P Health Care Equipment ETF

1.54%

Thrivent Small-Mid Cap ESG ETF

0.91%

Invesco S&P SmallCap Low Volatility ETF

0.71%

SPDR S&P 600 Small Cap Growth ETF

0.67%

Vanguard S&P Small-Cap 600 Growth Index Fund

0.67%

Franklin US Small Cap Multifactor Index ETF

0.65%

iShares S&P Small-Cap 600 Growth ETF

0.62%

OneAscent Small Cap Core ETF

0.62%

Invesco S&P SmallCap Health Care ETF

占比3.13%

First Trust Indxx Medical Devices ETF

占比1.7%

SPDR S&P Health Care Equipment ETF

占比1.54%

Thrivent Small-Mid Cap ESG ETF

占比0.91%

Invesco S&P SmallCap Low Volatility ETF

占比0.71%

SPDR S&P 600 Small Cap Growth ETF

占比0.67%

Vanguard S&P Small-Cap 600 Growth Index Fund

占比0.67%

Franklin US Small Cap Multifactor Index ETF

占比0.65%

iShares S&P Small-Cap 600 Growth ETF

占比0.62%

OneAscent Small Cap Core ETF

占比0.62%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据